Search - tctmd.com

Displaying 241 - 260 of 317

Sort: Relevancy | Date

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Daily News

Subestudio PLATO: El Ticagrelor se asocia a Menos Hemorragias, Infecciones y Muerte que el Clopidogrel tras CABG

September 27, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

Presentation

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Presenter: Christoph Varenhorst

September 26, 2012

News Daily News

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

L.A. McKeown

September 18, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

La Eficacia del Clopidogrel se Redujo en los Diabéticos tras sufrir un IM

September 07, 2012

News Daily News

Efficacy of Clopidogrel Diminished in Diabetics After MI

September 07, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Daily News

Subestudio PLATO: ‘La Paradoja del Fumador’ No Revela Efecto Alguno sobre el Ticagrelor

August 03, 2012

News Daily News

PLATO Substudy: ‘Smoker’s Paradox’ Shows No Effect on Ticagrelor

August 03, 2012

Presentation

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Presenter: Jan H. Cornel

August 02, 2012

News Daily News

Las Directrices Elevan el Ticagrelor a la Categoría de Antiplaquetario de 1ª Línea contra la Angina Inestable

Jason Kahn

July 17, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

News Daily News

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

July 12, 2012

News Daily News

Meta Análisis: Ajustar el Tratamiento según la Función Plaquetaria Mejora los Resultados

July 12, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

Advertisement

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

Subestudio PLATO: El Ticagrelor se asocia a Menos Hemorragias, Infecciones y Muerte que el Clopidogrel tras CABG

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

La Eficacia del Clopidogrel se Redujo en los Diabéticos tras sufrir un IM

Efficacy of Clopidogrel Diminished in Diabetics After MI

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

Subestudio PLATO: ‘La Paradoja del Fumador’ No Revela Efecto Alguno sobre el Ticagrelor

PLATO Substudy: ‘Smoker’s Paradox’ Shows No Effect on Ticagrelor

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Las Directrices Elevan el Ticagrelor a la Categoría de Antiplaquetario de 1ª Línea contra la Angina Inestable

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

Meta Análisis: Ajustar el Tratamiento según la Función Plaquetaria Mejora los Resultados

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content